The announcement was made in October. “We are pleased to announce Mike Martin will be joining ISPE and the ISPE Foundation as the new President and CEO,” said Jeffrey Biskup, Chair of the ISPE International Board of Directors and Executive Chairman of the Board for CRB. “ISPE extends its sincere gratitude to Michael Ruther-ford for his outstanding leadership and commitment during his tenure as Interim President and CEO. His guidance and dedication have been instrumental in ensuring ISPE’s continued success through this transition.”
Martin has had a distinguished career spanning more than 35 years in the pharmaceutical industry
Martin has had a distinguished career spanning more than 35 years in the pharmaceutical industry. Most of his career was with a large global pharmaceutical company, where he held leadership positions in engineering, operations, and project management across diverse global settings. Martin most recently served as the CEO of an engineering consulting company. His extensive experience includes leading large-scale capital projects in the US, Puerto Rico, China, and Ireland. He holds a bachelor’s degree in mechanical engineering and a master’s degree in business administration, as well as a professional engineering license.
“Mike Martin has successfully led diverse teams in various settings. He has demonstrated his ability to integrate into different cultures and inspire teams to achieve ambitious goals,” said Michael Rutherford.
As a seasoned professional, Martin’s experience spans a variety of pharmaceutical manufacturing operations, including dry product, aseptic, API, and delivery device manufacturing. He has led engineering, operational, and large-project organizations across these sectors. Martin has been a long-standing member of ISPE. Prior to assuming the role of President and CEO for ISPE and the ISPE Foundation, he served on both the ISPE International Board of Directors and the ISPE Foundation Board.
